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Objectives: The Helicobacter pylori virulence-associated genes in hepatobiliary patients, including
vacA, iceA, babA2, cagA and cagE, have not been reported. The aim of this study was to investigate these
genes and the association of those and the clinical outcomes in hepatobiliary diseases.
Methods: Eighty H. pylori-PCR-positive cases were obtained from hepatobiliary patients, representing
both cholangiocarcinoma (CCA) (n = 58) and cholelithiasis (n = 22). The diversity of virulence genes was
examined by polymerase chain reaction and DNA sequencing. Phylogenetic analysis of cagA was
determined using the maximum parsimony method.
Results: The vacAs1a + c/m1, iceA1 and babA2 genes were the most predominant genotypes in both
CCA and cholelithiasis patients. The cagA and cagE genes were found significantly more frequently in
patients with CCA than those with cholelithiasis (P < 0.05). The cagA positive samples were the Western-
type cagA and showed that almost all of the detected sequences in Thai hepatobiliary and Thai gastric
cancer patients were classified in the same cluster but separated from the cluster of Japan and other
countries.
Conclusions: The cagA and cagE genes may be associated in the pathogenesis of hepatobiliary
diseases, especially of CCA. Besides the bacterial variation, other host factors may be involved in the
pathogenesis of hepatobiliary cancer.
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Introduction
Helicobacter pylori is well known as a causative agent of gastric
adenocarcinoma.1 Helicobacter pylori is genetically diverse with
a spectrum of virulence factors so infection with different
H. pylori strains will lead to diverse clinical outcomes.2 The
virulence factors of H. pylori include vacA, iceA, babA2, cagA
and cagE, which play various and important roles in
pathogenesis.3–5
Cholangiocarcinoma (CCA) is an adenocarcinoma of the
bile duct epithelium and this primary liver cancer has a high
incidence in Northeast Thailand.6 The presence of H. pylori in
patients with hepatobiliary diseases has been investigated and the
virulence-associated genes, vacA and cagA, detected.7,8 Previous
research confirmed an association of H. pylori and CCA: the
former was observed to accelerate biliary inflammation and pro-
liferation.9 However, the association between H. pylori virulence-
associated genes (vacA, iceA, babA2, cagA and cagE) and clinical
outcomes of hepatobiliary diseases has not been reported, particu-
larly vis-à-vis CCA.
The vacuolating cytotoxin A gene (vacA) is present in all
H. pylori strains10 and is associated with the severity of gas-
trointestinal diseases.11 The vacA gene comprises diverse signalling
parts (s1a, s1b, s1c and s2) and a middle region (m1 and m2). The
activity of this toxin is higher in the s1/m1 than the s1/m2 subtype
and low or absent in the s2/m2 subtype.12
The induction by contact with the epithelium gene (iceA) has
been identified as the up-regulator after adhering to the epithelial
cells.13 The iceA gene has two major allelic sequence variants,
designated iceA1 and iceA2.14 Helicobacter pylori possessing the
iceA1 gene are significantly more associated with peptic ulcers and
related to the severity of gastric inflammation.3,13
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The blood group antigen-binding adhesion gene (babA)
encodes membrane-bound adhesin that binds the blood-group
antigen Lewisb, present on gastric epithelial cells.15 There are three
bab alleles (babA1, babA2 and babB) of H. pylori, but only the
babA2 gene shows Lewisb-binding activity.16 The presence of the
babA2 gene is associated with duodenal ulceration and gastric
cancer, whereas strains negative for babA2 are associated with
gastritis.16
The cytotoxin-associated gene A (cagA) is located at the end of
the cagA pathogenicity islands (cag PAI) and is considered an
important marker of H. pylori.17 Helicobacter pylori cagA-positive
strains have been observed to be more virulent than the H. pylori
cagA-negative strains.18 The CagA protein is associated with
mucosal inflammation by increasing interleukin (IL)-8 secretion
and stimulation of cell proliferation.18–20 The EPIYA motifs (Glu-
Pro-Ile-Tyr-Ala) are located at the 3′ region of the CagA protein
and these motifs are subdivided to EPIYA A, B, C and D; based on
different sequences in front of, and behind, the motif.21 EPIYA A
and B are mostly present in all CagA proteins, whereas EPIYA C
and D are present in the CagA Western and East Asian type,
respectively.17 Infection with East Asian positive strains is associ-
ated with the severity of inflammation among patients with gas-
tritis than those with Western positive strains.22 Moreover, the East
Asian CagA showed a more significant effect on growth of the
gastric mucosa than the Western CagA.23
Inside the cag PAI, cagE is a marker and essential for transloca-
tion and phosphorylation of CagA.24 Previous research showed
that H. pylori cagE positive strains are associated with the severity
of clinical outcomes of gastrointestinal diseases.25
In spite of research into the prevalence of H. pylori in hepato-
biliary diseases, an association between H. pylori virulence-
associated genes and clinical outcomes in hepatobiliary diseases
has not been previously reported. We, therefore, investigated the
genotyping of vacA, iceA, babA2, cagA and cagE in H. pylori-
infected hepatobiliary patients (specifically those with CCA and
cholelithiasis) and the association of those genes and clinical out-
comes. In order to clarify the association between the diversity of
cagA and the frequency of gastro-hepatobiliary diseases in various
countries, the diversity of cagA in H. pylori strains from gas-
troduodenal diseases of a selection of countries was compared
with that of hepatobiliary diseases using phylogenetic analysis.
Methods
Patients and clinical samples
Bile samples were obtained from 140 patients operated on at
Srinagarind Hospital, Faculty of Medicine, Khon Kaen University.
There were 80 hepatobiliary patients considered as H. pylori-
positive by PCR assay of whom 58 had CCA and 22 had cholelithi-
asis. The 16 cases in the control group were obtained from
autopsies, which indicated that four cases were H. pylori PCR
positive. Patients with gastrointestinal diseases and hepatitis virus
infection were excluded from the study. This study was approved by
the Ethics Committee of Khon Kaen University (HE 450525) and
performed in accordance with the Helsinki Declaration. All of the
patients provided informed consent before participating in the
study.
DNA extraction
Bile samples were diluted with 1 volume of sterile phosphate-
buffered saline (PBS) and centrifuged at 13 000 g before collecting
the bile pellet, which was re-suspended with lysis buffer [contain-
ing 4 ml of proteinase K (20 mg/ml)] and incubated at 55°C for 3 h.
The mixture was subsequently incubated with 4 ml RNase (25 mg/
ml) at 37°C for 1 h. Then, 300 ml protein precipitation solution
was added and centrifuged at 13 000 g for 5 min. Genomic DNA
in a supernatant was precipitated by 2 volumes of absolute
ethanol. The precipitated DNA in the supernatant was purified in
a DNA-purified column and washed two times with washing
buffer. Finally, the DNA was eluted using a buffer and stored at
-20°C until used.
PCR amplification of ureA, vacA, iceA, babA2, cagA
and cagE
The primer sequences and PCR condition for ureA (used for
detection and confirmation of H. pylori), the virulence genes and
genotyping of vacA, iceA, babA2, cagA and cagE were designed
based on published research3,26–34 with a modification to the PCR
mixture constituents and conditions (Table 1). The PCR was per-
formed in a total volume of 50 ml containing 1¥ PCR buffer (RBC
Bioscience, Taipei, Taiwan), 0.2 mM dNTP, 0.2 mM of each primer
(0.5 mM for babA2 and cagA sequencing), 1.25 units of Taq DNA
polymerase (RBC Bioscience) and 500 ng of genomic DNA in
each sample. The PCR assay was performed using a GeneAmp
PCR system 9600 (Perkin Elmer, Waltham, MA, USA). The ampli-
fied PCR products were determined by electrophoresis on 1.5–2%
agarose gel. After staining with ethidium bromide, bands were
visualized under a UV illuminator.
DNA sequencing and EPIYA motifs analysis
The amplicons of partial cagA were purified and sequenced
using a DYEnamic ET Dye Terminator Cycle Sequencing kit
from the MegaBace 1000 DNA Analysis System (GE Healthcare
Life Sciences, Little Chalfont, UK). The cagA sequences were
subsequently analysed for EPIYA motifs by translating the amino
acid sequence using a BMC Search Launcher program (Baylor
College of Medicine).
Phylogenetic analysis of cagA
In order to clarify the phylogenetic relationship of cagA, H. pylori
cagA+ strains from Thai patients with hepatobiliary diseases and
H. pylori cagA+ strains from those with gastroduodenal diseases,
reports from Thailand (northeastern), Japan, China, Vietnam,
Iran, USA and the Philippines were reviewed. Partial sequences of
cagA were aligned using the clustalw program. Of the Thai
patients with hepatobiliary disease, 17 cases of CCA and 1 case of
cholelithiasis with cagA positive strains were included. Addition-
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ally, we simultaneously analysed the DNA sequences of Western
type cagA from ethnic northeast Thai patients with gastric cancer
(GC196 and GC145). Of the Japanese patients, three strains of
Western type cagA were included (AB190942, AB190948, and
AB190950). Other strains included a Chinese (AF247651), a Viet-
namese (FJ798969), an Iranian (FJ849781), two USA American
mixed race grouping (AB015414 and AB015415) and two Filipino
(GU173858 and GU173862) were also analysed. A phylogenetic
tree was constructed using the maximum parsimony method.
Reliability of the tree was confirmed using bootstrap re-sampling
and reconstruction with 1000 replicates (using MEGA software
version 4.0; Center for Evolutionary Medicine and Informatics,
Tempe, AZ, USA)).
Statistical analysis
Chi-square (c2) or Fisher’s exact test were used to analyse the
categorical data in the CCA, cholelithiasis and the control
group. A P-value less than 0.05 were considered as statistically
significant.
Results
Helicobacter pylori-infected patients were evaluated for the rela-
tionship of age and gender (Table 2). CCA had a correlation with
age (41–60 years) and male gender whereas cholelithiasis was cor-
related with female gender (P < 0.05).
Prevalence of vacA genotypes
The prevalence of vacA, iceA, babA2, cagA and cagE was examined
in 80 of the H. pylori-infected patients with hepatobiliary diseases
(CCA and cholelithiasis). All of the vacA genes detected in the
CCA, cholelithiasis and control groups were the s1 type (100%).
Among the vacA s1 subtypes, vacA s1a+c was more prevalent than
the other subtypes in both the CCA and cholelithiasis patients
Table 1 Primer sequences and PCR conditions
Genes Primer sequences PCR condition PCR
size (bp)
Ref.
ureA gene
(Nested PCR)
OF-GCTAATGGTAAATTAGTTCCTGG
OR-CTCCTTAATTGTTTTTACATAGTTG
IF-AGTTCCTGGTGAGTTGTTCTTAA
IR-AACCACGCTCTTTAGCTCTGTC
94°C 30 s, 62°C 30 s,72°C 30 s (40 cycle)
94°C 30 s, 59°C 30 s,72°C 30 s (40 cycle)
411
350
26
cagA gene
(Nested PCR)
OF-5′–AGACAACTTGAGCGAGAAAG–3′
OR-5′–TATTGGGATTCTTGGAGGGG–3′
OF-5′–AGACAACTTGAGCGAGAAAG–3′
IR-5′–GGAGGCGTTGGTGTATTTGA–3′
94oC 30 s, 55oC 30 s,72oC 1.5 min (35 cycle
94oC 30 s, 57oC 30 s,72oC 30 s (35 cycle)
320
307
27
cagA-Western F-5′–GGAACCCTAGTCGGTAATG–3′
R-5′–TTTCAAAGGGAAAGGTCCGCC–3′
94°C; 20 s., 60°C; 20 s., 72°C; 40 s. (35 cycles) 501 28,29
cagA-East Asian F-5′–GGAACCCTAGTCGGTAATG–3′
R-5′–AGAGGGAAGCCTGCTTGATT–3′
94°C; 20 s., 60°C; 20 s., 72°C; 40 s. (35 cycles) 495 28,29
cagA sequencing F-5′–GGAACCCTAGTCGGTAATG–3′
R-5′–ATCTTTGAGCTTGTCTATCG–3′
94°C; 30 s., 57°C; 1 min., 72°C; 30 s. (35 cycles) 550–800 28
vacAs1/s2 F-5′–ATGGAAATACAACAAACACAC–3′
R-5′–CTGCTTGAATGCGCCAAAC–3′
94°C; 1 min, 58°C; 1 min, 72°C; 1 min (35 cycles) 259/286 30
vacAs1a F-5′–GTCAGCATCACACCGCAAC–3′
R-5′–CTGCTTGAATGCGCCAAAC–3′
94°C; 1 min, 60°C; 1 min, 72°C; 1 min (35 cycles) 190 30
vacAs1b F-5′–AGCGCCATACCGCAAGAG–3′
R-5′–CTGCTTGAATGCGCCAAAC–3′
94°C; 1 min, 60°C; 1 min, 72°C; 1 min (35 cycles) 187 30
vacAs1c F-5′–CTCTCGCTTTAGTGGGGYT–3′
R-5′–CTGCTTGAATGCGCCAAAC–3′
94°C; 1 min, 60°C; 1 min, 72°C; 1 min (35 cycles) 213 31
vacAs2 F-5′–GCTAACACGCCAAATGATCC–3′
R-5′–CTGCTTGAATGCGCCAAAC–3′
94°C; 30 s, 60°C; 1 min, 72°C; 1 min (35 cycles) 199 32
vacAm1/m2 F-5′–CAATCTGTCCAATCAAGCGAG–3′
R-5′–GCGTCAAAATAATTCCAAGG–3′
94°C; 1 min, 55°C; 1 min, 72°C; 1 min (35 cycles) 567/642 30
iceA1 F-5′–GTGTTTTTAACCAAAGTATC–3′
R-5′–CTATAGCCATTATCTTTGCA–3′
94°C; 1 min, 57°C; 1 min, 72°C; 1 min (35 cycles) 247 3
iceA2 F′-5′–GTTGGGTATATCACAATTTAT–3′
R′-5′–TTTCCCTATTTTCTAGTAGGT–3′
94°C; 1 min, 57°C; 1 min, 72°C; 1 min (35 cycles) 229 3
babA2 F′-5′ – CCAAACGAAACAAAAAGCGT–3′
F′-5′ – GCTTGTGTAAAAGCCGTCGT–3′
94°C; 1 min, 45°C; 1 min, 72°C; 1 min (35 cycles) 271 33
cagE F′-5′ – TTGAAAACTTCAAGGATAGGATAGAGC – 3′
F-5′ – GCCTAGCGTAATATCACCATTACCC – 3′
94°C; 1 min, 53°C; 45 s, 72°C; 1 min (35 cycles) 508 34
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(Table 3). Among those in the control group, vacA s1a was
encountered more frequently than any other subtype. A compari-
son among the three groups, revealed no significant relationship
vis-à-vis the vacA s1 subtype.
The vacA m1 gene was found significantly more frequently
than the vacA m2 alleles in patients with either CCA or cholelithi-
asis. The vacA m1 gene was found only in the control group;
however, the difference between these three groups was not signifi-
cant (Table 3). The combined vacA genotype (viz., vacA s1a +
c/m1) was the predominant subtype among patients with either
CCA or cholelithiasis and there was no statistically significant
association between the combination vacA subtype and clinical
outcome (data not shown).
Table 2 Distribution of 87 hepatobiliary patients, according to age
and gender
Hepatobiliary diseases Total
CCA Cholelithiasis n = 80(%)
n = 58(%) n = 22(%)
Age (years)
<20 0 2 (9.1) 2 (2.5)
20–40 0 1 (4.5) 1 (1.3)
41–60 39 (67.2)* 7 (31.8) 46 (57.5)
>60 19 (32.8) 12 (54.5) 31 (38.8)
Gender
Male (M) 35 (60.3)* 6 (27.3) 41 (51.3)
Female (F) 23 (39.7) 16 (72.7)* 39 (48.7)
*Significant difference between CCA and cholelithiasis (P < 0.05).
Table 3 Distribution of Helicobacter pylori vacA, iceA, babA2, cagA and cagE genotypes in hepatobiliary diseases
Genes CCA Cholelithiasis Control group Total (CCA and
cholelithiasis)
n = 58 (%) n = 22 (%) n = 4 (%) n = 80 (%)
vacA s types
s1 58 (100) 22 (100) 4 (100) 80 (100)
s1a 15 (25.9) 7 (31.8) 2 (50) 22 (27.5)
s1c 10 (17.2) 3 (13.6) 1 (25) 13 (16.3)
s1a+c 33 (56.9) 12 (54.5) 1 (25) 45 (56.2)
s2 0 (0) 0 (0) 0 (0) 0 (0)
vacA m types
m1 53 (91.4) 19 (86.4) 4 (100) 72 (90.0)
m2 5 (8.6) 3 (13.6) 0 (0) 8 (10.0)
iceA
iceA1 29 (50.0) 8 (36.4) 1 (25) 37 (46.3)
iceA2 7 (12.1) 2 (9.1) 0 (0) 9 (11.3)
iceA1+A2 5 (8.6) 2 (9.1) 0 (0) 7 (8.8)
iceA - 17 (29.2) 10 (45.5) 3 (75) 27 (33.8)
babA2
babA2+ 41 (70.7) 12 (54.5) 1 (25) 53 (66.2)
babA2- 17 (29.3) 10 (45.5) 3 (75) 27 (33.8)
cagA+ 21 (36.2)a 2 (9.1) 0 (0) 23 (28.8)
Western type 21 (100) 2 (100) ND 23 (100)
East asian type 0 (0) 0 (0) ND 0 (0)
cagA- 37 (63.8) 20 (90.9) 4 (100) 57 (71.2)
cagE+ 17 (29.3)b 1 (4.5) 0 (0) 18 (22.5)
cagE- 41 (70.7) 21 (95.5) 4 (100) 62 (77.5)
cagA+/cagE+ 17 (29.3)c 1 (4.5) 0 (0) 18 (22.5)
cagA+/cagE- 4 (6.9) 1 (4.5) 0 (0) 5 (6.3)
cagA-/cagE+ 0 (0) 0 (0) 0 (0) 0 (0)
cagA-/cagE- 37 (63.8) 20 (91.0) 0 (0) 57 (71.2)
aSignificant difference of cagA between CCA and cholelithiasis (P < 0.05).
bSignificant difference of cagE between CCA and cholelithiasis (P < 0.05).
cSignificant difference of cagA+/cagE+ between CCA and cholelithiasis (P < 0.05).
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Prevalence of iceA genotypes
The iceA1 allele was the most commonly found among hepatobil-
iary patients (46.3%; 37/80). Among CCA patients, the respective
iceA1 and iceA2 genes were detected in 50.0% (29/58) and 12.1%
(7/58). Among cholelithiasis patients, the respective iceA1 and
iceA2 genes were detected in 36.4% (8/22) and 9.1% (2/22). The
combined iceA1 and iceA2 genes were detected in patients with
both CCA and cholelithiasis [8.6% (5/58) and 9.1% (2/22),
respectively], but the difference between the two was not signifi-
cant neither was the clinical outcome (Table 3).
Prevalence of the babA2 gene
The babA2 allele was found in 53 (66.2%) of the 80 hepatobiliary
patients: in 70.7% (41/58), 54.5% (12/22) and 25.0% (1/4) of
patients in the CCA, cholelithiasis and control group, respectively.
There was no significant difference among the patient groups
(Table 3).
Prevalence of the cagA genotypes
The cagA gene was detected in 28.8% (23/80) of the H. pylori-
infected hepatobiliary patients: in 36.2% (21/58) of those with
CCA and 9.1% (2/22) with cholelithiasis. The difference between
the groups was statistically significant (P < 0.05). The control
group showed cagA negative results (Table 3). Using DNA
sequencing and amino acid analysis, we found that 18 of the 23
samples contained EPIYA-ABC, which is the Western type of cagA
(Fig. 1). Additionally, 5 of the 23 contained EPIYA-AC (CCA2,
CCA7, and CCA15) and EPIYA-BC (CCA3 and GS2). The repeats
of each EPIYA motif were not found.
Prevalence of the cagE gene
The presence of the cagE gene was found in 22.5% (18/80) of
hepatobiliary patients: 29.3% (17/64) of those with CCA and
4.5% (1/22) with cholelithiasis. The difference was statistically
significant (P < 0.05) (Table 3). The combination of cagA+ and
cagE+ was detected in 29.3% (17/58) of patients with CCA and
4.5% (1/22) of those with cholelithiasis. The difference was statis-
tically significant (P < 0.05) (Table 3).
Combination genotypes of H. pylori
The relationship of the combination genotype in hepatobiliary
diseases was analysed (data not shown). The rank of the combi-
nations found were: (i) vacA s1a+c/m1, iceA-, babA2-, cagA-, cagE-
(17.5%); (ii) vacA s1a+c/m1, iceA1+, babA2+, cagA-, cagE- (12.5%);
(iii) vacA s1a+c/m1, iceA1+, babA2+, cagA+, cagE+ (11.3%); and (iv)
vacA s1a/m1, iceA-, babA2-, cagA-, cagE- (8.8%) followed by the
other combinations (data not shown). The difference among the
the patient groups was not statistically significant.
Phylogenetic analysis of the partial cagA gene
The genetic relationships of the Western type cagA (EPIYA-ABC),
among the 18 Thai hepatobiliary patients (CCA = 17 and
cholelithiasis = 1), the Thai (northeastern) patients with gastric
cancer and the reference strains detected in gastroduodenal dis-
eases in Japan, China, the USA and the Philippines, were deter-
mined using maximum parsimony (Fig. 2). The results showed
that the partial DNA sequences of the Western type cagA for each
region were markedly distinguishable. The sequences of the
Western type cagA detected among patients from Japan, China,
Iran and the USA were grouped in the same cluster, indicating a
genetic similarity. By contrast, the Western type cagA detected
among Thai patients with hepatobiliary diseases formed a differ-
ent cluster: only one strain among the Thai patients (CCA8) was
genetically closer to those other groups. Furthermore, we found
that the Western type cagA sequences among the Thai patients
with hepatobiliary disease were included in the same cluster as the
Western type cagA sequences found among Thai patients with
gastric cancer (GC45 and GC196) and Filipino patients with gas-
tritis (GU173861 and GU173864) (Fig. 2).
Discussion
Helicobacter pylori was detected in patients with CCA significantly
more frequently than in those with cholelithiasis or the control
Figure 1 Examples of amino acid sequences of Western-type CagA showing EPIYA-ABC in CCA (CCA10 and CCA17), EPIYA-AC (CCA2)
and EPIYA-BC (CCA3)
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group and, in our previous study, the presence of H. pylori is
associated with biliary cell inflammation and proliferation.9 This
microorganism has been observed to induce a pathological effect
on hepatobiliary cells in animal models.35 These results indicate
that there is a likely correlation between H. pylori and hepatobil-
iary diseases, especially in liver carcinoma. The genetic variations
of H. pylori have been previously described and several virulence
genes that play a role in the pathogenesis of gastrointestinal tract.2
As there has been no report on genotyping of the H. pylori
virulence-associated genes in hepatobiliary diseases, we investi-
gated whether there was any such association including patients
with malignant CCA and benign cholelithiasis.
The cagA gene has been reported to be the most important
gene related to the severity of gastroduodenal diseases.17 It is
present in more than 90% of H. pylori strains isolated from gas-
troduodenal diseases in Thailand36 compared with 60–70% in
Western countries.25 Some researchers have shown that the cagA
positive strains, compared with cagA negative strains, signifi-
cantly increase the risk of developing gastric cancer.18,20 Our pre-
vious report demonstrated that cagA positive strains are not
significantly different among Thai patients with gastroduodenal
diseases.36 In order to prove the role of H. pylori in the hepato-
biliary tract, patients with gastroduodenal diseases were excluded
from the present study.
CCA 11
CCA 9
CCA 17
CCA 13
CCA 4
CCA 20
CCA 14
CCA 6
CCA 19
CCA 5
CCA 12
CCA 10
CCA 18
CCA 8
AB015414 USA
AB015415 USA
FJ849781 Iran
AF247651 China
AB190948 Okinawa
AB190950 Okinawa
AB190942 Okinawa
FJ798969 Vietnam
CCA 16
CCA 1
CCA 21
GC 145
GC 196
GS 1
GU173861 Philippines
GU173864 Philippines
Figure 2 Phylogenetic analysis of partial cagA sequences among ethnic northeast Thai patients with hepatobiliary diseases (cholangiocar-
cinoma: CCA and cholelithiasis or gallstone: GS) compared with 10 reference strains of Western type cagA in Japanese (AB190942,
AB190948, and AB190950), Chinese (AF247651), Iranians (FJ849781), Americans (USA) (AB015414 and AB015415), Vietnamese (FJ798969)
and Filipinos (GU173861 and GU173864). The Western CagA in Thai patients with gastric cancer (GC196 and GC145) was included in this
analysis. GU = gastric ulcer, GC = gastric cancer
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A previous report showed that a low prevalence of cagA positive
strains (43%) was found among Thai asymptomatic healthy
persons as compared with Japanese in whom a high prevalence of
cagA positive strains was found (85%).37 It is debated whether the
cagA positive gene is significantly more prevalent in CCA (36.2%)
than in cholelithiasis patients (9.1%) (P < 0.05).9 Chronic
cholestasis is an important factor involved in the development of
CCA;38 this condition is presumed to create a condition for
H. pylori survival.39,40 It is possible that the H. pylori obstructed by
cholestasis in CCA might increase the risk of exposure to H. pylori
toxigenic strains, especially cagA positive strains. These data indi-
cate that the cagA gene may be associated with hepatobiliary
malignancy as cited by Tiwari et al.8 and Huang et al.,7 who found
a correlation between the presence of the cagA gene in hepatobil-
iary diseases and liver cancer. Additionally, other components
of cagPAI and other virulence factors for H. pylori should be
emphasized.
The cagPAI encoded proteins for the type 4 secretion apparatus
to facilitate production of CagA, peptidoglycan and possibly other
bacterial factors in host cells, which are the main cause of inflam-
mation.41 A previous study showed that cagA, cagE, cagM and cagT
of cagPAI were used as useful markers for the risk of peptic ulcer
disease.42 In this study, besides cagA, cagE was also used as a
marker to confirm the presence of cagPAI. The cagE gene is one of
the components in cagPAI43 and is involved in the construction of
the bacterial transport system44 and induces IL-8 production in
gastric epithelial cells.43 As with the presence of the cagA gene
observed in this study, it was found that the cagE gene in patients
with CCA was significantly higher than in those with cholelithiasis
(P < 0.05), which is in accord with a previous report on the cagE
gene and gastric cancer.45 The combination of the cagA and cagE
positive genes was significantly more prevalent among patients
with CCA than in those with cholelithiasis (P < 0.05). The present
results show that the presence of the cagE gene is commonly found
with the cagA gene, which is a representation of cagPAI. It is,
therefore, concluded that the cagPAI may be involved in the pro-
gression of hepatobiliary cancer (especially CCA).
Dectecting cagA alone appears to be less important as a viru-
lence marker than determining the type and EPIYA motif.9,28 In
this study, the genotypes of the cagA gene were determined using
DNA sequencing. This study found that most of the cagA+ samples
were Western-type CagA (EPIYA-ABC). The East Asian type cagA
(EPIYA-ABD) and the repeated EPIYA motifs were not found in
patients with either CCA or cholelithiasis. Our previous study
showed that the Western type cagA was detected more commonly
than the East Asian type among Northeast Thai dyspeptic patients
and was found significantly more frequently in patients with a
peptic ulcer but was not significant in gastric cancer.46 In the
present study, the cagA gene was found in malignant (CCA) sig-
nificantly more often than in benign patients (cholelithiasis) but
the cagA genotype (Western type) for both was not significantly
different between groups. Other factors besides the EPIYA motifs
may, therefore, be correlated with the pathogenesis of CCA.
It is well known that the prevalence of gastric cancer in Japan is
very high.47 In order to determine whether the cagA of the
H. pylori strains found in hepatobiliary and gastroduodenal
patients in Thailand and other countries were similar, a phyloge-
netic analysis of the partial DNA sequences of Western type cagA
was determined. The results showed that most of the Western
cagA sequences among hepatobiliary patients in Thailand formed
a different cluster from that of the Western cagA sequences among
Japanese and patients from other countries. In addition, we found
that the Western cagA sequences among Thai hepatobiliary
patients were classified in the same cluster as the Western cagA
sequences of Thai patients with gastric cancer and Filipinos with
gastritis. It is therefore possible that the H. pylori detected in the
Thais with hepatobiliary and gastroduodenal diseases underwent
a similar evolution or that the H. pylori found in the hepatobiliary
patients might have first come from gastroduodenal sites. The
cluster difference between Thailand and Japan observed in this
study is similar to a previous report showing that all Western
CagA-positive Filipino strains in gastroduodenal patients were
classified in the same Western cluster, but not in the Japan–
Western cluster.48 These findings indicate that the variation of
bacterial strains might be involved in the development of diseases.
Other virulence genes have been reported to be associated with
gastroduodenal diseases.49 VacA affected multiple structural and
functional alterations in an epithelial cell line, such as vacuole
formation50 and induction of apoptosis. There has, however, been
no report on vacA genotypes in hepatobiliary disease. According
to our results, the vacA s1a+c/m1 genotypes were frequently
detected in patients with either CCA or cholelithiasis. Our find-
ings are similar to previous studies on gastroduodenal diseases, in
which the vacA s1/m1 genotypes were found more commonly
than the vacA s1/m2 genotype and the vacA s1b genotype was not
found at all.36,51,52 This accords with a previous report that found
that the vacA s1a+c was the most commonly detected genotype
among Northern Thai patients but that it was not associated with
clinical outcomes.52 Our results similarly showed no association
between the vacA genotypes and clinical outcomes for hepatobil-
iary diseases.
Helicobacter pylori iceA1 positive strains significantly increased
IL-8 production in human gastric epithelial cells (SGC7901) com-
pared with iceA1 mutant strains.53 Helicobacter pylori possessing
the iceA1 gene are significantly associated with the severity of
inflammation and peptic ulcer disease, whereas the iceA2 gene is
significantly associated with chronic gastritis and normal cases.54
The present study found that the iceA1 gene was the predominant
genotype in hepatobiliary diseases, but that there was no differ-
ence among patient groups, as with previous reports on gastric
diseases.36,55
The babA2 gene encodes the outer membrane protein that
binds to the Leb antigen in gastric cells and these H. pylori babA2
strains are associated with gastric cancer.16 We found a high preva-
lence of the babA2 gene among hepatobiliary patients but we did
not find any significant differences in the frequency of the babA2
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genotype between CCA and cholelithiasis patients, as reported
after an investigation on the association of this gene and clinical
outcomes of gastrointestinal diseases.36 A discrepancy, however,
may occur depending on: (i) the other outer membrane protein of
H. pylori, which may be involved in colonization of SabA adhesin
that binds to the Lex antigen;56 and, (ii) there may be a phase
variation of the other outer membrane proteins which may par-
ticipate in this process.57
We found a high prevalence of vacA s1 (s1a+s1c), vacA m1,
iceA1 and babA2 among Thai patients with hepatobiliary diseases,
albeit there was no significant difference between the various
genes and clinical outcomes, as has been noted with gastroduode-
nal diseases.36 Whereas the cagA and cagE genes were found to be
associated with patients with CCA (P < 0.05), over cholelithiasis,
the cagA and cagE genes were found in over 90% of those with
H. pylori infection.36 Based on our previous study,9 and other
studies in vitro58 and in vivo,49 cagA and cagE may play an impor-
tant role in the development of CCA. However, the role of cagPAI
on H. pylori survival in the hepatobiliary tract should be studied
further.
Additionally, the answer on why H. pylori could colonize in
hepatobiliary system, could might be explained by: (i) bile duct
obstruction in cholangitis is generally as a result of gallstone or
other factors leading to bacteria ascending from the duodenum
into the hepatobiliary system59 or (ii) the bile duct obstruction
caused by the effect of CCA38 which might increase a pressure
within the biliary system leading to bacterial influx into hepato-
biliary tract. However, H. pylori as a main causative factor or
co-factor in CCA could not conclude. The explanation of H. pylori
may be the main causative factor because we found significantly
more H. pylori associated with the inflammation and proliferation
surrounding tumor tissues in CCA patients9 whereas the explana-
tion of H. pylori may be the co-factor because the chronic
cholestasis had occurred resulting the obstruction of bile duct and
then the bacteria was ascended and increased the severity of
disease. Therefore, the role of H. pylori as the main causative
factor or co-factor should be further investigated.
Besides the variation of H. pylori genotypes, we found that
other host factors may be involved in the development of CCA
because of the association among age and gender with CCA.
In conclusion, the present research provides new evidence of
the prevalence of H. pylori virulence-associated genes in hepato-
biliary patients, especially CCA. There was no significant associa-
tion of the vacA, iceA and babA2 genotypes with the clinical status
of hepatobiliary diseases, whereas cagA and cagE genotypes was
associated with carcinogenesis of the CCA and might serve as
potential markers for prediction of the severity of hepatobiliary
diseases. The western-type cagA was the predominant genotype of
H. pylori found in hepatobiliary patients but did not associate
with the severity of disease. The pathogenesis of H. pylori and its
virulence-associated genes in the extra-gastrointestinal tract
should, however, be further clarified, particularly in an animal
model.
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